🇺🇸 FDA
Patent

US 10948495

Methods and reagents for analyzing protein-protein interfaces

granted A61PA61P37/06

Quick answer

US patent 10948495 (Methods and reagents for analyzing protein-protein interfaces) held by Revolution Medicines, Inc. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P37/06